If out of concern over cloning, the U.S. Congress succeeds in criminalizing embryonic stem-cell research that might bring treatments for Alzheimer's disease or diabetes - and Dr. Fukuyama lent his name to a petition that supported such laws - there would be real victims: present and future sufferers of those diseases.

In this quote, Gregory Stock addresses the ethical and societal implications of embryonic stem-cell research and its potential to provide treatments for diseases such as Alzheimer's and diabetes. He argues that if the U.S. Congress criminalizes this research due to concerns over cloning, it could have detrimental consequences for individuals currently suffering from these diseases, as well as future patients. Stock emphasizes the real victims of such laws would be those who could benefit from the medical advancements stem-cell research promises.

Stock also critiques Dr. Fukuyama, a prominent figure who lent his name to a petition supporting restrictions on stem-cell research. By linking Fukuyama's name to the petition, Stock suggests that the moral and ethical concerns about cloning might overshadow the immediate need for medical treatments that could help millions of people. His statement reflects the tension between ethical debates and the urgency of addressing healthcare needs through scientific innovation.

The origin of the quote is rooted in Stock's work as a biotech expert and author, particularly in the fields of biotechnology and genetics. His writing often explores the potential benefits and dangers of emerging technologies, especially in areas like genetic engineering and stem-cell research. Stock has been an advocate for advancing medical science to improve human health, which informs his position on the importance of allowing such research to move forward despite ethical concerns.

Ultimately, Stock’s quote underscores the complex ethical debate surrounding biotechnology and the balance between moral considerations and the potential to alleviate suffering. He warns that placing restrictions on stem-cell research based on concerns about cloning could hinder progress in finding life-saving treatments, ultimately causing harm to those who stand to benefit from such scientific advancements.